Skip to content

The effect of opioid sparing in high risk group of postoperative nausea and vomiting after thyroid surgery

The effect of opioid sparing in high risk group of postoperative nausea and vomiting after thyroid surgery

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072353
Enrollment
Unknown
Registered
2023-06-12
Start date
2023-06-12
Completion date
Unknown
Last updated
2023-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative nausea and vomiting

Interventions

opioid sparing group:opioid sparing
general anesthesia group:Full dose of opioids

Sponsors

First Affiliated Hospital of University of Science and Technology of China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Open thyroid surgery was performed at an selected time, Apfel score =2, patients could communicate normally, and could cooperate with the completion of preoperative evaluation and postoperative follow-up; 2. 19~65 years old; 3.ASA ? or ?

Exclusion criteria

Exclusion criteria: 1.Allergic to local anesthetics; 2.Severe liver and kidney dysfunction; 3.Severe cardiovascular and cerebrovascular diseases: cardiac function > Grade II; 4.The state of pregnancy; 5.Patients receiving opioid treatment, substance abuse or drug use for a long time; 6. Patients who do not provide informed consent; 7 Patients who are allergic to NSADIs or have a history of gastrointestinal ulcer surgery.

Design outcomes

Primary

MeasureTime frame
Postoperative nausea and vomiting;

Secondary

MeasureTime frame
Heart rate (HR) and blood pressure (BP);Intraoperative consumption of propofol and remifentanil;Visual analogue scale scores at 6h, 12h, 24h and 48h after surgery;

Countries

China

Contacts

Public ContactYanhu Xie

First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital)

xyh200701@sina.com+86 139 5601 3081

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026